Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Clinical trial NCT00032292 · COMPLETED

Trial details

NCT number: NCT00032292
Sponsor: Facet Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease

Start date: 2002-03-01
Primary completion: 2006-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.